P

Inventor

KELLERMANN SIRID-AIMEE

US14 patents
⚠️ This page may combine multiple inventors who share the name “KELLERMANN SIRID-AIMEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN FREMONT INC

7 patents
US7728113B2Jun 1, 2010

Methods of treating arthritic conditions with antibodies to M-CSF

AMGEN FREMONT INC21 citations92
US7932372B2Apr 26, 2011

Antibodies to MAdCAM

AMGEN FREMONT INC30 citations91
US7867494B2Jan 11, 2011

Anti-IgE antibodies

AMGEN FREMONT INC30 citations85
US10280219B2May 7, 2019

Antibodies to M-CSF

AMGEN FREMONT INC1 citations72
US7625549B2Dec 1, 2009

Determining the risk of human anti-human antibodies in transgenic mice

AMGEN FREMONT INC3 citations62
USRE45847EJan 19, 2016

Antibodies to MAdCAM

AMGEN FREMONT INC2 citations61
US9718883B2Aug 1, 2017

Antibodies to M-CSF

AMGEN FREMONT INC0 citations51

KELLERMANN SIRID-AIMEE

2 patents
US8198508B2Jun 12, 2012

Reducing the risk of human anti-human antibodies through V gene manipulation

KELLERMANN SIRID-AIMEE1 citations58
US8597615B2Dec 3, 2013

Methods of monitoring a human anti-human antibody response and inhibitors thereof

KELLERMANN SIRID-AIMEE0 citations48

WARNER LAMBERT CO

1 patent
US7326414B2Feb 5, 2008

Antibodies to M-CSF

WARNER LAMBERT CO86 citations98

AMGEN FREMONT

1 patent
US7592430B2Sep 22, 2009

Antibodies to M-CSF

AMGEN FREMONT22 citations90

PFIZER

1 patent
US10259872B2Apr 16, 2019

Antibodies to MAdCAM

PFIZER1 citations71

BEDIAN VAHE

1 patent
US8188249B2May 29, 2012

Nucleic acid molecules encoding antibodies to M-CSF

BEDIAN VAHE2 citations61

SCHERING CORP

1 patent
US6824781B2Nov 30, 2004

Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist

SCHERING CORP2 citations59